Frontline KEYTRUDA In Gastroesophageal Cancer: Patients I...

Frontline KEYTRUDA In Gastroesophageal Cancer: Patients In Immunotherapy Arm Had Significantly Lower Side Effects
Annual Meeting Photo

Annual Meeting
3 años 36 Visitas
Categoría:
Descripción:
Nicholas Rohs MD @NickRohsMD Of Mount Sinai Discusses Frontline KEYTRUDA In Gastroesophageal Cancer: Patients In Immunotherapy Arm Had Significantly Lower Side Effects.